Skip to navigation Skip to content

Acromegaly Program in Pharmaceutical Benefits Scheme (PBS) 012-18051100

Expand/Collapse all sectionsExpand all


Acromegaly restriction and item codes

Do not share this attachment externally. See Freedom of Information – Information Publication Scheme.

\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation Blueprint Migration\RDT Release Icons\32w\icon-hidden-attachment.pngPBS Acromegaly restriction and item codes

Contact details

PBS Complex Drugs Programs

Forms

Acromegaly - pasireotide - initial authority application form (PB181)

Acromegaly - pegvisomant - initial authority application form (PB225)

Services Australia website

Acromegaly

External websites

PBS schedule for Acromegaly

FAQs from Service Officers

Table 1: see  Table 2  in Processing Complex Authority Required Listings for FAQs about all Complex programs.

Item

Description

1

Can a patient change from pasireotide to pegvisomant or vice versa?

There is no change restriction. A prescriber would need to request an initial PBS approval for each medication.